MENU
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Context Therapeutics (CNTX) Ownership - Who owns Context Therapeutics?
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more
Profile
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
78.36M
P/E Ratio
N/A
Total Cash
83.52M
Projected Growth
N/A
Total Debt
167.32K
Revenue
N/A
Risk (Beta)
2.48
Dividend Yield
N/A
Total Cash/Share
0.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CNTX
Capitalization
78.4M
P/E Ratio
N/A
Risk (Beta)
2.48
Dividend Yield
N/A
Total Cash
83.5M
Total Cash/Share
0.93
Total Debt
167K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
82.5M
P/B Ratio
0.95
Cash Flow
N/A
Earnings
-0.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
89.7K
Current Ratio
19.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-38.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.03
Shares Held By Institutions
55.2M
Shares Outstanding - Current
89.7M
Total Liabilities
4.61M
Total Volume MTD
N/A
Value
1
Gain YTD
-16.810
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CNTX showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com